Literature DB >> 9351760

Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen.

L D Roman1, J C Felix, L I Muderspach, A Agahjanian, D Qian, C P Morrow.   

Abstract

OBJECTIVE: To quantify the risk of residual invasion when cervical conization reveals microinvasive squamous carcinoma and to determine whether any factors affect this risk.
METHODS: We reviewed the charts and histopathology slides of 87 women who underwent a conization that contained microinvasive squamous carcinoma, followed by either a repeat conization or hysterectomy. Depth of invasion, number of invasive foci, and status of the internal margin and post-conization endocervical curettage (ECC) were assessed. The findings were correlated with the presence of residual invasion.
RESULTS: Significant predictors of residual invasion included status of the internal margin (residual invasion present in 22% of women with an involved margin versus 3% with a negative margin; P < .03) and the combined status of the internal margin and post-conization ECC (residual invasion in 4% of patients if both negative, 13% if one positive, and 33% if both positive; P < .015). Depth of invasion and number of invasive foci in the conization specimen were not significant. The power of this study to detect a 25% difference in the risk of residual invasion was 73% for depth of invasion and 75% for number of invasive foci.
CONCLUSION: Women with microinvasive squamous carcinoma in a conization specimen in which both the internal conization margin and post-conization ECC are negative have a low risk of residual invasion and are candidates for follow-up or simple hysterectomy. If either the internal margin or the post-conization ECC contains dysplasia or carcinoma, the risk of residual invasion is high and warrants repeat conization before definitive treatment planning.

Entities:  

Mesh:

Year:  1997        PMID: 9351760     DOI: 10.1016/s0029-7844(97)00414-6

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Predictive Factors for Residual Disease After Conization in Cervical Cancer.

Authors:  Glauco Baiocchi; Thiago Pereira Diniz; Graziele Bovolim; Bruna Tirapelli Gonçalves; Lillian Yuri Kumagai; Henrique Mantoan; Carlos Chaves Faloppa; Andrea Paiva Gadelha Guimaraes; Alexandre Andre Balieiro Anastacio da Costa; Levon Badiglian-Filho; Louise De Brot
Journal:  Ann Surg Oncol       Date:  2021-02-10       Impact factor: 5.344

Review 2.  Early cervical neoplasia: advances in screening and treatment modalities.

Authors:  Brent Tierney; Shannon N Westin; Matthew P Schlumbrecht; Pedro T Ramirez
Journal:  Clin Adv Hematol Oncol       Date:  2010-08

Review 3.  Perspective for prophylaxis and treatment of cervical cancer: an immunological approach.

Authors:  Marjorie Jenkins; Maurizio Chiriva-Internati; Leonardo Mirandola; Catherine Tonroy; Sean S Tedjarati; Nicole Davis; Nicholas D'Cunha; Lukman Tijani; Fred Hardwick; Diane Nguyen; W Martin Kast; Everardo Cobos
Journal:  Int Rev Immunol       Date:  2012-02       Impact factor: 5.311

4.  Loop electrosurgical excision procedure combined with cold coagulation for cervical intraepithelial neoplasia and adenocarcinoma in-situ: a feasible treatment with a low risk of residual/recurrent disease.

Authors:  Eun Jung Yang; Nae Ry Kim; Ji Yeon Choi; Wook Youn Kim; Sun Joo Lee
Journal:  Infect Agent Cancer       Date:  2020-10-06       Impact factor: 2.965

5.  Efficacy of loop electrosurgical excision procedure with cold coagulation for treating cervical intraepithelial neoplasia: A two center cohort study.

Authors:  Hee Seung Kim; Jeong Eun Kwon; Jeong Ha Kim; Anna Kim; Na Ra Lee; Miseon Kim; Maria Lee; Dong Hoon Suh; Yong Beom Kim
Journal:  Obstet Gynecol Sci       Date:  2017-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.